Halozyme Therapeutics, Inc.
HALONASDAQ Global Select·USD·Closed
Halozyme Therapeutics, Inc.
HALONASDAQ·USD·Closed
$71.71
−2.22%
$71.71
−$1.63 (2.22%)
52W Range
76thpctl
Volume
1.98M
Mkt Cap
8.43BUSD
P/E
22.4TTM
Div Yield
–ann
Not investment advice.Read full disclaimer
The stock is priced moderately relative to its earnings
This company doesn't pay a dividend
A mid-sized company. Balances growth potential with stability
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Volume
Mkt Cap
P/E
Div Yield
52W Range
Mid-range
Volume
Market Cap
Mid-cap company
P/E Ratio
Moderately valued
Div Yield
No dividend